Page last updated: 2024-10-17

bupropion and Peripheral Vascular Diseases

bupropion has been researched along with Peripheral Vascular Diseases in 1 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.

Research Excerpts

ExcerptRelevanceReference
"Physician advise, nicotine replacement therapy and Bupropion are all evidence based treatments that have success in increasing the likelihood of permanent smoking cessation."4.82Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach. ( Bradbury, AW; Hobbs, SD, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hobbs, SD1
Bradbury, AW1

Reviews

1 review available for bupropion and Peripheral Vascular Diseases

ArticleYear
Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2003, Volume: 26, Issue:4

    Topics: Arteriosclerosis; Bupropion; Counseling; Humans; Nicotine; Peripheral Vascular Diseases; Smoking Ces

2003